ABSTRACT
Evidence .....................................................................................................300 Historical Account of Human PD: Nutraceutical Therapeutics .....................301 Palliative Treatment Vs. Prevention/Reduced Risk: Epidemiological Research ............................................................................. 306
Strengths and Weakness of Available Data ................................................306 Global PD Patterns .....................................................................................307 Correlations and Patterns Within Population Subsets ...............................308
